Join
Live feed
·
NEWSReleasevia Quantisnow
BridgeBio Pharma Inc. logo
Invitae Corporation logo

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
BBIO· BridgeBio Pharma Inc.NVTA· Invitae Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.), NVTA (Invitae Corporation) and more on Quantisnow.